Skip to main content
. 2015 Apr 16;3(4):360–367. doi: 10.12998/wjcc.v3.i4.360

Table 3.

Adverse events

Adverse events Group A Group B
Arterial hypertension 0% 0%
Arterial hypotension 0% 0%
Bradycardia 0% 0%
Cough 0% 0%
Headache 0% 0%
Nausea 6.20% 6.20%
Pain 6.20% 6.20%
Residual neuromuscular blocking 0% 0%
Vomiting 0% 0%
Others 0% 6.20%